Wells Fargo’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Wells Fargo’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,900	Closed	-$43.7K	–	7664
2024 Q1	$43.7K	Buy	8,900 +1,356	+18%	+$6.44K	﹤0.01%	5312
2023 Q4	$27.5K	Buy	7,544 +1,966	+35%	+$5.39K	﹤0.01%	5515
2023 Q3	$12.4K	Sell	5,578 -5,672	-50%	-$15.8K	﹤0.01%	5746
2023 Q2	$38.3K	Buy	11,250 +6,854	+156%	+$24.7K	﹤0.01%	5526
2023 Q1	$17.5K	Buy	+4,396	New	+$19.4K	﹤0.01%	5684
2022 Q4	–	Sell	-415	Closed	-$2K	–	7805
2022 Q3	$2K	Sell	415 -166	-29%	-$817	﹤0.01%	6221
2022 Q2	$2K	Buy	+581	New	+$3.71K	﹤0.01%	6405

Wells Fargo's TGAN Position: Q2 2024 in Review

Wells Fargo sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 8,900 shares — an estimated $43.7K sold.

Wells Fargo first reported a position in TGAN in Q2 2022 and held it in 7 quarters. The position peaked at $43.7K in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

Wells Fargo reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Wells Fargo sold 8,900 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $43.7K.
Wells Fargo first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
Wells Fargo's Transphorm, Inc. Common Stock position peaked at $43.7K in Q1 2024.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.